Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 10, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125249

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for BLA: 125249

Tradename:	ARCALYST
Applicant:	Regeneron Pharmaceuticals
Ingredient:	rilonacept
Patents:	22
Approval Date:	Feb 27, 2008
Suppliers: see list	1

US Patents for BLA: 125249

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Regeneron Pharmaceuticals	ARCALYST	rilonacept	VIAL; SINGLE-USE	125249	001	2008-02-27	Start Trial	The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA)	2034-04-21	RX	Orphan	search
Regeneron Pharmaceuticals	ARCALYST	rilonacept	VIAL; SINGLE-USE	125249	001	2008-02-27	Start Trial	Occlugel (Jouy en Josas, FR) Centre National de la Recherche Scientifique (CNRS) (Paris, FR) Assistance Publique Hopitaux de Paris (Paris, FR) Universite Paris Diderot--Paris 7 (Paris, FR)	2031-03-09	RX	Orphan	search
Regeneron Pharmaceuticals	ARCALYST	rilonacept	VIAL; SINGLE-USE	125249	001	2008-02-27	Start Trial	Laureate Institute For Brain Research (Tulsa, OK)	2034-12-04	RX	Orphan	search
Regeneron Pharmaceuticals	ARCALYST	rilonacept	VIAL; SINGLE-USE	125249	001	2008-02-27	Start Trial	CardioForecast Ltd. (London, GB)	2037-01-12	RX	Orphan	search
Regeneron Pharmaceuticals	ARCALYST	rilonacept	VIAL; SINGLE-USE	125249	001	2008-02-27	Start Trial	Drexel University (Philadelphia, PA)	2034-08-04	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Colorcon

Dow

Merck

McKinsey

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.